Seeking Alpha

Zoll Medical (ZOLL +5.8%) surges at the open following strong FQ1 results which showed revenue...

Zoll Medical (ZOLL +5.8%) surges at the open following strong FQ1 results which showed revenue from its LifeVest wearable defibrillator worn by patients at risk for sudden cardiac arrest, jumped 45% to $32.3M and now accounts for 20% of revenue. Zoll seems back on track after the strong quarter and Medicare's recent reversal of a decision to change its coverage policy.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|